Cytotoxic T cells and viral hepatitis

Journal of Clinical Investigation

Volumn 99, Issue 7, 1997, Pages 1472-1477

  Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN RECOGNITION; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS MUTATION;

EID: 0030892283     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119308     Document Type: Review

References (50)

1. Chisari, F.V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Ann. Rev. Immunol. 13:29-60.
2. Bertoletti, A., C. Ferrari, F. Fiaccadori, A. Penna, R. Margolskee, H.J. Schlicht, P. Fowler, S. Guilhot, and F.V. Chisari. 1991. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl. Acad. Sci. USA. 88:10445-10449.
3. Missale, G., A. Redeker, J. Person, P. Fowler, S. Guilhot, H.-J. Schlicht, C. Ferrari, and F.V. Chisari. 1993. HLA-A31 and HLA-Aw68 restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:751-762.
4. Nayersina, R., P. Folwer, S. Guilhot, G. Missale, A. Cerny, H.-J. Schlicht, A. Vitiello, R. Chesnut, J.L. Person, A.G. Redeker, and F.V. Chisari. 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150: 4659-4671.
5. Rehermann, B., J. Person, A. Redeker, P. Fowler, M. Brown, B. Moss, A. Sette, and F.V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
6. Rehermann, B., D. Lau, J.H. Hoofnagle, and F.V. Chisari. 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest. 97:1655-1665.
7. Rehermann, B., C. Ferrari, C. Pasquinelli, and F.V. Chisari. 1996. The hepatitis B virus persists for decades after recovery from acute viral hepatitis despite active maintenance of a cytotoxic T lymphocyte response. Nat. Med. 2: 1104-1108.
8. Chazouilleres, O. 1994. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet. 343:142-146.
9. Thiers, V., E. Nakajima, D. Kremsdorf, D. Mack, H. Schellekens, F. Driss, A. Goudeau, J. Wands, J. Sninsky, P. Tiollais, et al. 1988. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet. 2:1273-1276.
10. Moriyama, T., S. Guilhot, K. Klopchin, B. Moss, C.A. Pinkert, R.D. Palmiter, R.L. Brinster, O. Kanagawa, and F.V. Chisari. 1990. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science (Wash. DC). 248:361-364.
11. Ando, K., T. Moriyama, L.G. Guidotti, S. Wirth, R.D. Schreiber, H.J. Schlicht, S. Huang, and F.V. Chisari. 1993. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178:1541-1554.
12. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:25-36.
13. Guidotti, L.G., P. Borrow, M.V. Hobbs, B. Matzke, I. Gresser, M.B.A. Oldstone, and F.V. Chisari. 1996. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA. 93:4589-4594.
14. Davis, G.L., J.H. Hoofnagle, and J.G. Waggoner. 1984. Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon. J. Med. Virol. 14:141-147.
15. Franco, A., C. Ferrari, A. Sette, and F.V. Chisari. 1995. Viral mutations, T cell receptor antagonism and escape from the immune response. In Current Opinion in Immunology. A. Sher and R. Ahmed, editors. Current Biology Ltd., London. 524-531.
16. Ando, K., L.G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R.D. Schreiber, H.J. Schlicht, S. Huang, and F.V. Chisari. 1994. Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245-3253.
17. Galle, P.R., W.J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P.H. Krammer, and L. Runkell. 1995. Involvement of the CD95 (APO-1/ Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223-1230.
18. Alcami, A., and G.L. Smith. 1995. Cytokine receptors encoded by pox-viruses: a lesson in cytokine biology. Immunol. Today. 16:474-178.
19. Fischer, M., L. Runkel, and H. Schaller. 1995. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit. Virus Genes. 10:99-102.
20. Bertoletti, A., A. Costanzo, F.V. Chisari, M. Levrero, M. Artini, A. Sette, A. Penna, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180:933-943.
21. Kalams, S.A., R.P. Johnson, A.K. Trocha, M.J. Dynan, S. Ngo, R.T. D'Aquila, J.T. Kurnick, and B.D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-1271.
22. Bertoletti, A., A. Sette, F.V. Chisari, A. Penna, M. Levrero, M. DeCarli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T cell receptor antagonists for antiviral cytotoxic T cells. Nature (Lond.). 369:407-410.
23. + population. Science (Wash. DC). 260:98-100.
24. Niewiesk, S., S. Daenke, C.E. Parker, G. Taylor, J. Weber, S. Nightingale, and C.R.M. Bangham. 1994. The transactivator gene of human T-cell leukemia virus type 1 is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J. Virol. 68:6778-6781.
25. Klenerman, P., S. Rowland-Jones, S. McAdams, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, et al. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature (Lond.). 369:403-407.
26. Rehermann, B., C. Pasquinelli, S.M. Mosier, and F.V. Chisari. 1995. Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J. Clin. Invest. 96:1527-1534.
27. Brunetto, M.R., M.M. Giarin, F. Oliveri, E. Chiaberge, M. Baldi, A. Alfarano, A. Serra, G. Saracco, G. Verme, H. Will, and F. Bonino. 1991. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc. Natl. Acad. Sci. USA. 88:4186-4190.
28. Hasegawa, K., J. Huang, S.A. Rogers, H.E. Blum, and T.J. Liang. 1994. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J. Virol. 68:1651-1659.
29. Scaglioni, P.P., M. Melegari, and J.R. Wands. 1997. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J. Virol. 71: 345-353.
30. Guidotti, L.G., B. Matzke, C. Pasquinelli, J.M. Shoenberger, C. Rogler, and F.V. Chisari. 1996. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice. J. Virol. 70:7056-7061.
31. Farci, P., H.J. Alter, S. Govindarajan, D.C. Wong, R. Engle, R.R. Lesniewski, I.K. Mushahwar, S.M. Desai, R.H. Miller, N. Ogata, and R.H. Purcell. 1992. Lack of protective immunity against reinfection with hepatitis C virus. Science (Wash. DC). 258:135-140.
32. Shimizu, Y.K., M. Hijikata, A. Iwamoto, H.J. Alter, R.H. Purcell, and H. Yoshikura. 1994. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68:1494-1500.
33. Farci, P., H.J. Alter, D.C. Wong, R.H. Miller, S. Govindarajan, R. Engle, M. Shapiro, and R.H. Purcell. 1994. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA. 91:7792-7796.
34. Koziel, M.J., D. Dudley, N. Afdhal, Q.-L. Choo, M. Houghton, R. Ralston, and B.D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522-7532.
35. Koziel, M.J., D. Dudley, N. Afdhal, A. Grakoui, C.M. Rice, Q.-L. Choo, M. Houghton, and B.D. Walker. 1995. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 96:2311-2321.
36. Koziel, M.J., D. Dudley, J.T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B.D. Walker. 1992. Intrahepatic cytotoxic T lymphocyte specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339-3344.
37. Cerny, A., J.G. McHutchison, C. Pasquinelli, M.E. Brown, M.A. Brothers, B. Grabscheid, P. Fowler, M. Houghton, and F.V. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95:521-530.
38. Battegay, M., J. Fikes, A.M. Di Bisceglie, P.A. Wentworth, A. Sette, E. Celis, W.-M. China, A. Grakoui, C.M. Rice, K. Kurokohchi, J.A. Berzofsky, J.H. Hoofnagle, S.M. Feinstone, and T. Akatsuka. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69:2452-2470.
39. Kita, H., T. Moriyama, T. Kaneko, I. Harase, M. Nomura, H. Miura, and I. Nakamura. 1993. HLA-B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology. 18:1039-1044.
40. Erickson, A.L., M. Houghton, Q.L. Choo, A.J. Weiner, R. Ralston, E. Muchmore, and C.M. Walker. 1993. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J. Immunol. 151: 4189-4199.
41. Rehermann, B., K.-M. Chang, J.G. McHutchison, R. Kokka, M. Houghton, and F.V. Chisari. 1996. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response, disease activity and viral load in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1432-1440.
42. Ballardini, G., P. Groff, P. Pontisso, F. Giostra, R. Francesconi, M. Lenzi, D. Zauli, A. Albeti, and F.B. Bianchi. 1995. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. J. Clin. Invest. 95:2067-2075.
43. Hiramatsu, N., N. Hayashi, K. Katayama, K. Mochizuki, Y. Kawanishi, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology. 19:1354-1359.
44. Mullbacher, A., and M. Lobigs. 1995. Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum. Immunity. 3:207-214.
45. Weiner, A., A.L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A.L. Hughes, M. Houghton, and C.M. Walker. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA. 92:2755-2759.
46. Kakumu, S., T. Ishikawa, T. Wakita, K. Yoshioka, M. Takayanagi, H. Tahara, and A. Kusakabe. 1994. Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B. Am. J. Gastroenterol. 89:92-96.
47. + T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J. Virol. 69:3358-3368.
48. Inoue, M., S. Kakumu, K. Yoshioka, Y. Tsutsumi, T. Wakita, and M. Arao. 1989. Hepatitis B core antigen specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. J. Immunol. 142:4006-4011.
49. + surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J. Immunol. 152:3074-3087.
50. Napoli, J., G.A. Bishop, P.H. McGuinness, D.M. Painter, and G.W. McCaughan. 1996. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th 1-associated cytokines. Hepatology. 24:759-765.